Of all the home care agency types that transact in the M&A market, Medicare-certified home health agencies occupy a unique position. They command the highest EBITDA multiples in the sector — frequently 5× to 7× or higher — but they also require the most careful transaction structuring.
The reason is regulatory complexity. A Medicare-certified home health agency carries certifications, provider agreements, and licensure that are tied to a specific legal entity and operating location — and all of these require active management during a sale to ensure the buyer can operate the business without interruption post-close.
This guide explains what differentiates Medicare skilled home health agency sales from other home care transactions and what both sides should know before entering the process.
Medicare-skilled home health (sometimes called “Medicare Part A home health” or “skilled home health”) carries several characteristics that buyers value:
Reimbursement stability. Medicare is a federal payor — it doesn’t change the way Medicaid does at the state level. While PDGM and rate changes create volatility, Medicare revenue is generally more predictable than Medicaid and more scalable than private pay.
Clinical complexity and specialization. Skilled home health agencies provide nursing, physical therapy, occupational therapy, speech therapy, and medical social work under physician orders — this is meaningfully more complex than non-skilled home care and creates higher barriers to entry.
Certificate of Need (CON) constraints in some states. Roughly a dozen states maintain CON requirements for home health. In CON states, acquiring an already-licensed agency may be the only practical way to enter a market. This scarcity drives significant premium pricing.
Referral network depth. A high-performing skilled home health agency with strong hospital discharge relationships, SNF partnerships, and physician referral bases has built an asset that is expensive to replicate organically.
A Medicare-certified home health agency’s Provider Agreement — the agreement with CMS that allows billing for Medicare services — is entity-specific. It belongs to the legal entity, not the underlying business activities.
In a stock sale (or membership unit sale for an LLC), the entity changes hands but remains intact. The Provider Agreement transfers automatically with the entity and there is no need to re-enroll with Medicare — though the buyer must notify Medicare of the ownership change through CMS Form 855A within a specified timeframe.
In an asset sale, the Medicare Provider Agreement does NOT transfer automatically. The buyer must apply for a new Provider Agreement and enroll as a new Medicare provider, which can take 60–180+ days depending on the MAC (Medicare Administrative Contractor) processing times. During this gap, Medicare billing may be interrupted unless the transaction includes a “change of ownership” (CHOW) filing that captures the Provider Agreement.
The CHOW process: CMS allows a “change of ownership” where the assets and Provider Agreement transfer together — but this requires specific filings with CMS, often processed through the MAC, and does not happen automatically. It requires coordination with healthcare regulatory counsel and advance planning.
Medicare-certified home health agencies are also licensed at the state level. State home health licenses are typically non-transferable entity assets — meaning in an asset sale, the buyer needs to apply for a new license in the acquiring entity.
State licensing timelines vary dramatically: from a few weeks in some states to 6+ months in others. In some states, there are moratoriums on new home health licenses — making an asset sale structure genuinely impractical.
Implication: In states with complex licensing environments, a stock sale is usually the preferred structure — it preserves the existing license without requiring a new application. However, stock sales carry higher liability exposure for the buyer (all entity liabilities come with the purchase), so buyers often push for reps and warranties insurance or escrow arrangements to offset this risk.
Many Medicare-certified home health agencies hold accreditation from CAHQ (Community Health Accreditation Partner), The Joint Commission (JCAHO), or CHAP, which serves as their Medicare deemed status survey in lieu of direct CMS oversight.
Accreditation is organization-specific. When a sale occurs, the new operating entity or newly enrolled provider typically needs to apply for re-accreditation or transfer accreditation — a process each accrediting body handles differently. This creates a potential gap in Medicare billing authority and survey requirements.
Planning tip: Contact the accrediting body early — ideally before the sale process begins — to understand the transfer or reapplication requirements and timeline.
At the time of ownership change, the existing provider number typically closes out a cost report period. The seller may have obligations related to the final cost report (including potential Medicare settlements or recoupment), which must be allocated between buyer and seller in the purchase agreement.
Medicare requires Home Health Agencies to maintain OASIS data continuity and submit quality reporting data. During a transition, there must be careful handoff of patient records, OASIS assessments, and Home Health Compare data responsibility. The purchase agreement should address patient record transfer protocols.
Before bringing a skilled home health agency to market, sellers should conduct an internal compliance review covering:
Why this matters: Any compliance issues found by buyers in due diligence are used as leverage to reduce purchase price or demand escrow. Issues found post-close create indemnification claims. It is always less expensive to identify and clean up problems before marketing the business.
Buyers of Medicare-certified agencies scrutinize:
Understand your:
Buyers pay particular attention to referral source concentration. If 30%+ of Medicare volume comes from a single hospital system or physician group, that’s a concentration risk. Document your referral relationships and, where possible, demonstrate that relationships extend beyond the owner/founder to the clinical team and case managers.
| Factor | Stock Sale | Asset Sale |
|---|---|---|
| Medicare Provider Agreement | Transfers with entity | Requires CHOW filing or new enrollment |
| State Licensure | Transfers with entity | Requires new application |
| Accreditation | Transfer process with accreditor | Re-application required |
| Liabilities | All entity liabilities transfer | Buyer selects which liabilities to assume |
| Transaction speed | Generally faster | Longer (licensing/enrollment timelines) |
| Tax treatment (seller) | Capital gains on all proceeds | Ordinary income on certain asset classes |
| Buyer preference | Often preferred for operational continuity | Often preferred for clean liability assumption |
The practical reality: Most Medicare-certified home health agency transactions are structured as stock sales or transactions with CHOW filings — because the regulatory complexity of an asset sale without Provider Agreement transfer is too disruptive to operations.
Outstanding survey history. A deficiency-free most-recent state survey is worth meaningful value. Poor surveys or open Plans of Correction are discounted heavily.
Strong CAHPS star ratings. Home Health Care CAHPS ratings that fall in the 4–5 star range (particularly for patient communication, specific care issues, and overall rating) demonstrate quality and may support premium positioning in competitive markets.
Medicare Advantage managed care contracts. As MA penetration grows (now 50%+ of Medicare beneficiaries nationally), established MA contracts with major payers (Humana, UnitedHealthcare, Aetna) have standalone value.
Depth of clinical staff. A skilled team of experienced RNs, PTs, OTs, and SLPs with low turnover is a genuine value driver. High clinical staff turnover raises questions about management and culture.
Geographic territory and CON position. In CON states, the geographic service territory may have additional value as a barrier to entry.
| Agency Characteristic | Approximate EBITDA Multiple Range |
|---|---|
| Sub-$500K EBITDA, single market | 3.5× – 4.5× |
| $500K–$1.5M EBITDA, competitive market | 4.5× – 6.0× |
| $1.5M–$3M EBITDA, strong market position | 5.5× – 7.0× |
| $3M+ EBITDA, scale + CON state premium | 6.0× – 8.0×+ |
| Turnaround / post-survey deficiency | 2.5× – 3.5× |
Note: These ranges are indicative. Your specific multiple will depend on payor mix, market, compliance history, growth trajectory, and buyer competitive dynamics. Medicare-certified agencies in CON states (FL, MD, NJ, etc.) frequently trade at the upper end of ranges.
Given the regulatory complexity, sellers of Medicare-certified home health agencies benefit significantly from working with an M&A advisor who understands the sector specifically, not just general healthcare M&A.
Your advisor should be able to:
Schedule a confidential consultation with Hendon Partners →
Hendon Partners advises on the sale of Medicare-certified home health agencies nationwide. Our team has deep experience with CMS Conditions of Participation, CHOW filings, and multi-state licensing complexities that arise in skilled home health transactions.
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.
